![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/24/2902897/0/en/Helsinn-Group-announces-AKYNZEO-fosnetupitant-palonosetron-injection-is-now-available-in-a-ready-to-use-vial-in-the-US.html
https://www.pharmaceutical-technology.com/news/helsinn-angelini-distribution-deal/
https://www.globenewswire.com/news-release/2024/05/27/2888406/0/en/Helsinn-and-Angelini-Pharma-sign-a-partnership-agreement-renewal-to-commercialize-AULIN-and-MESULID-in-Bulgaria-Czech-Republic-Hungary-Poland-Romania-and-Slovak-Republic.html
https://www.globenewswire.com//news-release/2023/10/10/2757386/0/en/Helsinn-closes-financing-agreement-with-BancaStato-to-support-business-objectives-and-growth.html
https://www.globenewswire.com/news-release/2023/06/12/2686333/0/en/Helsinn-announces-publication-of-data-evaluating-impact-of-AKYNZEO-fosnetupitant-palonosetron-on-treatment-outcomes-and-healthcare-costs.html
https://www.globenewswire.com/news-release/2023/02/03/2601287/0/en/Helsinn-announces-publication-of-new-data-evaluating-impact-of-NEPA-netupitant-palonosetron-on-hospital-costs.html
https://www.globenewswire.com/news-release/2023/01/10/2586068/0/en/Helsinn-closes-financing-agreement-with-Oberland-Capital.html
https://www.globenewswire.com/news-release/2023/01/09/2585134/0/en/Helsinn-announces-the-appointment-of-Dr-Melanie-Rolli-as-Group-Chief-Executive-Officer.html
https://www.globenewswire.com/news-release/2022/10/18/2536307/0/en/Helsinn-publishes-new-data-evaluating-chlormethine-gel-s-mode-of-action-in-Dermatology-and-Therapy.html